Pluristyx – Tomorrow’s Cell Therapies, Today
Pluristyx is an advanced therapy tool which helps businesses and expert researchers solve manufacturing challenges in the field of drug development, regenerative medicine and cell & gene therapy.
Pluristyx provides seamless client support by offering CMC consulting, contract development services, and research and clinical-grade Ready-to-Use (RTU™) and Ready-To-Differentiate (RTD™) Pluripotent Stem Cells at a commercial scale.
In doing so, Pluristyx effectively decouples the hassles of expansion and banking from differentiation and product development, allowing early-stage companies to focus precious resources on therapeutic application rather than manufacturing hurdles, with the ultimate goal of advancing promising laboratory discoveries into patients.
Pluristyx strives to become the leading resource and stem cell provider for early stage cell and gene therapy companies. It’s an ambitious mission, but one that will accelerate the path to commercialisation for revolutionary products to treat serious and chronic human diseases.
The Complete Cell Manufacturing Solution
Pluristyx serves the cell therapy and regenerative medicine community through three complimentary product offerings:
Fully-characterized Ready-to-Use (RTU™), Ready-to-Differentiate (RTD™) Stem Cells and Differentiated Cells for reliable and consistent downstream product development
Contract Laboratory Development Services
Process Development, Testing & Analytics, Scale-up, and GMP Cell Banking in Pluristyx-operated laboratory and GMP Manufacturing facilities
Cell Therapy Consulting
Expertise in Chemistry, Manufacturing, and Control (CMC), GMP Manufacturing, Facilities & Operations, and Investigational New Drug Submission for cell therapies and advanced biologics
Contact us for a quote
MediSport Scientific, Exchange Station, Tithebarn Street, Liverpool, L2 2QE